• Corpus ID: 20875126

The inhibitory effect of (111)In-DTPA(0)-octreotide on intrahepatic tumor growth after partial hepatectomy.

@article{Slooter2002TheIE,
  title={The inhibitory effect of (111)In-DTPA(0)-octreotide on intrahepatic tumor growth after partial hepatectomy.},
  author={Gerrit Dirk Slooter and Arend G. J. Aalbers and Wouter A. P. Breeman and Coen A Hiemstra and Richard L. Marquet and Eric Paul Krenning and Casper H.J. van Eijck},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year={2002},
  volume={43 12},
  pages={
          1681-7
        }
}
UNLABELLED The aim of this animal study was to evaluate whether peptide receptor radionuclide therapy with (111)In-diethylenetriaminepentaacetic acid (DTPA)(0)-octreotide was able to reduce tumor growth even under tumor growth-stimulating conditions induced by partial hepatectomy (PHx). METHODS Rats underwent 70% PHx or sham operation. The development of hepatic metastases was determined 21 d after direct injection of somatostatin receptor (SS-R)-positive or SS-R-negative tumor cells into the… 
Receptor-Mediated Tumor Targeting with Radiopeptides. Part 1. General Concepts and Methods: Applications to Somatostatin Receptor-Expressing Tumors
TLDR
A comprehensive overview of the literature on receptor-mediated tumor targeting with the different radiopeptides currently studied is presented, demonstrating that peptide radiopharmaceuticals have gained an important position in clinical medicine.
Targeted Auger electron radiotherapy of HER2-amplified breast cancer.
TLDR
It was hypothesized that the NLS-peptides would mediate the translocation of covalently linked In-trastuzumab molecules into the nuclei of HER2overexpressing breast cancer cells where subcellular-range Auger electrons are most damaging to DNA and lethal to cells.